Vaccine Development Strategies - Refocusing Efforts to Address New Challenges -





Published: February 2014 | Pages: 60 | Format: PDF

 Vaccines are one of the most important healthcare advances and have saved millions of lives through immunizing against some of the most deadly diseases. With protection against a number of key viral and bacterial diseases now effectively generated, vaccine R&D is turning to areas of unmet need. Preventative vaccination in adults and against pathogens that affect the developing world is increasingly becoming a focus. Research into therapeutic vaccination for patients already affected by a disease is also gathering pace. There are several different approaches to preventative vaccination, most of which have been effectively employed to reduce the incidence of certain diseases or, in some cases, eradicate them completely. 

 Scope 

 

  •  This report providers readers with an understanding of the key developing trends in the vaccines market and how these are expected to impact on the overall competitive landscape, the major players and forecasted growth 
  •  This report provides an overview of the preventative vaccines market, including insights into clinical development strategies, recommendations for maximizing potential for development of preventative vaccines and discussion about potential areas of growth in the near term 
  •  The report provides in-depth analysis of the developing landscape for therapeutic vaccines, including recent activities of major pharmaceutical companies, insight into the challenges being faced by companies developing therapeutic vaccines and recommendations on clinical development strategies to overcome these potential obstacles and hurdles 
  •  The report assesses the evolving competitive vaccines landscape, profiling the major pharmaceutical players and providing information into the emerging vaccines companies and assessing how the vaccines market is expected to develop in the short to medium term. 

 

 Key Reasons to Purchase 

 

  •  The report will enable you to understand how key factors such as the emerging markets, new therapeutic targets and innovative technologies are becoming increasingly important to profitability and commercial return for vaccine companies as traditional targets and populations become satisfied 
  •  Gain insights on the key challenges that exist to further vaccine development 
  •  Compare considerations in both therapeutic and preventive vaccines markets 

 

 Executive Summary 

 Methodology 

 Vaccines: an overview 

 Emerging trends 

 Key issues in vaccine development and marketing 

 Considerations in preventative vaccine development 

 Clinical trial considerations 

 Regulatory strategy 

 Market access 

 Developing world strategies 

 Considerations for therapeutic vaccine development 

 Therapy area focus 

 Clinical trial considerations 

 Regulatory strategy 

 Market access 

 Key players and commercial opportunity 

 Companies leading the way 

 Commercial opportunity 

 Appendix